Home › Funds › WAYCROSS PARTNERS, LLC › COR

WAYCROSS PARTNERS, LLC position in COR

CENCORA INC · Health Care

WAYCROSS PARTNERS, LLC reported holding 6,258 shares of COR (CENCORA INC) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.15% of its reported portfolio and ranking #37 among its reported holdings. WAYCROSS PARTNERS, LLC has disclosed COR holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.26K sh
Reported value held$1.88M
Portfolio Weight0.15%
First reportedQ3 2023
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WAYCROSS PARTNERS, LLC's COR position evolved

WAYCROSS PARTNERS, LLC first disclosed a stake in COR in Q3 2023 at 16,150 shares (US$2.9M). The position peaked in Q3 2025 at 15,000 shares, worth US$4.7M. Across 11 filings, WAYCROSS PARTNERS, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 6,258 shares valued at US$1.9M. Notable position changes include a 38% trim in Q4 2023 (shares rose 18% over the following quarter), a 50% increase in Q1 2025 (shares rose 8% over the following quarter), a 33% trim in Q4 2025 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.15K $2.91M New
Q4 2023 10.00K $2.05M Reduce
Q1 2024 10.00K $2.43M Hold
Q2 2024 10.00K $2.25M Hold
Q3 2024 10.00K $2.25M Hold
Q4 2024 10.00K $2.25M Hold
Q1 2025 15.00K $4.17M Add
Q2 2025 15.00K $4.50M Hold
Q3 2025 15.00K $4.69M Hold
Q4 2025 10.00K $3.38M Reduce
Q3 2026 6.26K $1.88M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COR and 13F data

COR (CENCORA INC) is a Health Care company. 33 other funds we track also report a position in COR — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.58B), Mawer Investment Management Ltd. (US$413.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COR

All COR fund holders →

FAQ

How long has WAYCROSS PARTNERS, LLC held COR?

WAYCROSS PARTNERS, LLC has disclosed COR holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is WAYCROSS PARTNERS, LLC's current position in COR?

As of Q3 2026, WAYCROSS PARTNERS, LLC holds 6.26K shares of COR (CENCORA INC), valued at $1.88M, representing 0.15% of its reported portfolio and ranking #37.

Has WAYCROSS PARTNERS, LLC been buying or selling COR?

In the latest 13F filing (Q3 2026), WAYCROSS PARTNERS, LLC newly opened its position in COR. The position peaked in Q3 2025 at 15.00K shares.

Which other funds hold COR?

Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Mawer Investment Management Ltd., among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.